nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Aprepitant for refractory nivolumab-induced pruritus
|
Ito, Jiro |
|
2017 |
109 |
C |
p. 58-61 4 p. |
artikel |
2 |
Association of MTH1 expression with the tumor malignant potential and poor prognosis in patients with resected lung cancer
|
Fujishita, Takatoshi |
|
2017 |
109 |
C |
p. 52-57 6 p. |
artikel |
3 |
Cigarette smoke extract induces EGFR-TKI resistance via promoting EGFR signaling pathway and ROS generation in NSCLC cell lines
|
Zhang, Lu |
|
2017 |
109 |
C |
p. 109-116 8 p. |
artikel |
4 |
Clinical and pathological characteristics of EGFR mutation in operable early-stage lung adenocarcinoma
|
Yotsukura, Masaya |
|
2017 |
109 |
C |
p. 45-51 7 p. |
artikel |
5 |
Clinical outcomes of platinum-based chemotherapy according to T790M mutation status in EGFR-positive non-small cell lung cancer patients after initial EGFR-TKI failure
|
Yoshida, Tatsuya |
|
2017 |
109 |
C |
p. 89-91 3 p. |
artikel |
6 |
Contents
|
|
|
2017 |
109 |
C |
p. v-vi nvt p. |
artikel |
7 |
EGFR T790M mutation testing within the osimertinib AURA Phase I study
|
Dearden, Simon |
|
2017 |
109 |
C |
p. 9-13 5 p. |
artikel |
8 |
Evaluation of the VeriStrat® serum protein test in patients with advanced squamous cell carcinoma of the lung treated with second-line afatinib or erlotinib in the phase III LUX-Lung 8 study
|
Gadgeel, Shirish |
|
2017 |
109 |
C |
p. 101-108 8 p. |
artikel |
9 |
Growth pattern-based grading of pulmonary adenocarcinoma—Analysis of 534 cases with comparison between observers and survival analysis
|
Boland, J.M. |
|
2017 |
109 |
C |
p. 14-20 7 p. |
artikel |
10 |
Indications for invasive mediastinal staging in patients with early non-small cell lung cancer staged with PET-CT
|
Gao, Sarah J. |
|
2017 |
109 |
C |
p. 36-41 6 p. |
artikel |
11 |
Lepidic predominant adenocarcinoma and invasive mucinous adenocarcinoma of the lung exhibit specific mucin expression in relation with oncogenic drivers
|
Duruisseaux, Michaël |
|
2017 |
109 |
C |
p. 92-100 9 p. |
artikel |
12 |
Optimal front-line ALK (anaplastic lymphoma kinase) directed therapy
|
Gadgeel, Shirish M. |
|
2017 |
109 |
C |
p. 147-148 2 p. |
artikel |
13 |
Quantitative cell-free circulating EGFR mutation concentration is correlated with tumor burden in advanced NSCLC patients
|
Zhu, Yan-juan |
|
2017 |
109 |
C |
p. 124-127 4 p. |
artikel |
14 |
Recurrent dysphasia due to nivolumab-induced encephalopathy with presence of Hu autoantibody
|
Raskin, Jo |
|
2017 |
109 |
C |
p. 74-77 4 p. |
artikel |
15 |
Reduced Smad4 expression and DNA topoisomerase inhibitor chemosensitivity in non-small cell lung cancer
|
Ziemke, Michael |
|
2017 |
109 |
C |
p. 28-35 8 p. |
artikel |
16 |
Research letter: Evaluating the future pathological N descriptors for lung cancer staging in a UK population
|
Edwards, Tim |
|
2017 |
109 |
C |
p. 149-151 3 p. |
artikel |
17 |
Stereotactic body radiotherapy for operable early-stage non-small cell lung cancer
|
Eriguchi, Takahisa |
|
2017 |
109 |
C |
p. 62-67 6 p. |
artikel |
18 |
Surgery Versus Chemotherapy and Radiotherapy For Early and Locally Advanced Small Cell Lung Cancer: A Propensity-Matched Analysis of Survival
|
Wakeam, E. |
|
2017 |
109 |
C |
p. 78-88 11 p. |
artikel |
19 |
Systematic identification of cancer-related long noncoding RNAs and aberrant alternative splicing of quintuple-negative lung adenocarcinoma through RNA-Seq
|
Zhang, Lu |
|
2017 |
109 |
C |
p. 21-27 7 p. |
artikel |
20 |
Targeting BAP1: a new paradigm for mesothelioma
|
Schunselaar, L.M. |
|
2017 |
109 |
C |
p. 145-146 2 p. |
artikel |
21 |
The components of somatostatin and ghrelin systems are altered in neuroendocrine lung carcinoids and associated to clinical-histological features
|
Herrera-Martínez, Aura D. |
|
2017 |
109 |
C |
p. 128-136 9 p. |
artikel |
22 |
The impact of preoperative elevated serum C-reactive protein on postoperative morbidity and mortality after anatomic resection for lung cancer
|
Lopez-Pastorini, Alberto |
|
2017 |
109 |
C |
p. 68-73 6 p. |
artikel |
23 |
Therapy-induced E-cadherin downregulation alters expression of programmed death ligand-1 in lung cancer cells
|
Suda, Kenichi |
|
2017 |
109 |
C |
p. 1-8 8 p. |
artikel |
24 |
Trends, practice patterns and underuse of surgery in the treatment of early stage small cell lung cancer
|
Wakeam, E. |
|
2017 |
109 |
C |
p. 117-123 7 p. |
artikel |
25 |
Uncommon EGFR mutations in advanced non-small cell lung cancer
|
O’Kane, Grainne M. |
|
2017 |
109 |
C |
p. 137-144 8 p. |
artikel |
26 |
Vitiligo in a patient with lung adenocarcinoma treated with nivolumab: A case report
|
Uenami, Takeshi |
|
2017 |
109 |
C |
p. 42-44 3 p. |
artikel |